Cite
APA Citation
Chiappori, A. A., Otterson, G. A., Dowlati, A., Traynor, A. M., Horn, L., Owonikoko, T. K., Ross, H. J., Hann, C. L., Abu Hejleh, T., Nieva, J., Zhao, X., Schell, M., & Sullivan, D. M. (2016). a Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer. Oncologist, 21, 1163–1164e. http://access.bl.uk/ark:/81055/vdc_100151234628.0x00003a